KPRX CIK: 1372514

Kiora Pharmaceuticals Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.7
FY22:
−10.4
FY23:
−9.56
FY24:
8.56
FY25:
−9.96
Change from FY21 to FY25
millions USD
FY21:
−0.16
FY22:
0.01
FY23:
0
FY24:
−22.7
FY25:
14.4
Change from FY21 to FY25
millions USD
FY21:
17.6
FY22:
8.62
FY23:
5.97
FY24:
15.5
FY25:
0.27
millions USD
FY21:
6.67
FY22:
−1.89
FY23:
−3.55
FY24:
1.34
FY25:
4.90
(positive)
Change from FY21 to FY25
millions USD
FY21:
−10.7
FY22:
−10.4
FY23:
−9.56
FY24:
8.55
FY25:
−10.1

All amounts in millions USD Data source:SEC EDGAR